221 related articles for article (PubMed ID: 25024059)
1. Predictors of dementia in Parkinson's disease; findings from a 5-year prospective study using the SCOPA-COG.
Zhu K; van Hilten JJ; Marinus J
Parkinsonism Relat Disord; 2014 Sep; 20(9):980-5. PubMed ID: 25024059
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for hallucinations in Parkinson's disease: results from a large prospective cohort study.
Zhu K; van Hilten JJ; Putter H; Marinus J
Mov Disord; 2013 Jun; 28(6):755-62. PubMed ID: 23520046
[TBL] [Abstract][Full Text] [Related]
3. Course and risk factors for excessive daytime sleepiness in Parkinson's disease.
Zhu K; van Hilten JJ; Marinus J
Parkinsonism Relat Disord; 2016 Mar; 24():34-40. PubMed ID: 26846609
[TBL] [Abstract][Full Text] [Related]
4. Parkinson's disease progression at 30 years: a study of subthalamic deep brain-stimulated patients.
Merola A; Zibetti M; Angrisano S; Rizzi L; Ricchi V; Artusi CA; Lanotte M; Rizzone MG; Lopiano L
Brain; 2011 Jul; 134(Pt 7):2074-84. PubMed ID: 21666262
[TBL] [Abstract][Full Text] [Related]
5. Postural instability and gait are associated with severity and prognosis of Parkinson disease.
van der Heeden JF; Marinus J; Martinez-Martin P; Rodriguez-Blazquez C; Geraedts VJ; van Hilten JJ
Neurology; 2016 Jun; 86(24):2243-50. PubMed ID: 27178702
[TBL] [Abstract][Full Text] [Related]
6. A 12-year population-based study of freezing of gait in Parkinson's disease.
Forsaa EB; Larsen JP; Wentzel-Larsen T; Alves G
Parkinsonism Relat Disord; 2015 Mar; 21(3):254-8. PubMed ID: 25603767
[TBL] [Abstract][Full Text] [Related]
7. [Psychometric attributes of Scales for Outcomes in Parkinson's Disease-Cognition (SCOPA-Cog), Castilian language].
Martínez-Martín P; Frades-Payo B; Rodríguez-Blázquez C; Forjaz MJ; de Pedro-Cuesta J;
Rev Neurol; 2008 Oct 1-15; 47(7):337-43. PubMed ID: 18841543
[TBL] [Abstract][Full Text] [Related]
8. Clinical predictors of cognitive impairment and psychiatric complications in Parkinson's disease.
Campos LS; Guimarães RP; Piovesana LG; Azevedo PC; Santos LM; D'Abreu A
Arq Neuropsiquiatr; 2015 May; 73(5):390-5. PubMed ID: 26017203
[TBL] [Abstract][Full Text] [Related]
9. Relationship between sleep disorders and other non-motor symptoms in Parkinson's disease.
Kurtis MM; Rodriguez-Blazquez C; Martinez-Martin P;
Parkinsonism Relat Disord; 2013 Dec; 19(12):1152-5. PubMed ID: 23953775
[TBL] [Abstract][Full Text] [Related]
10. Importance of Balance-Gait Disorder as a Risk Factor for Cognitive Impairment, Dementia and Related Non-Motor Symptoms in Parkinson's Disease.
Lichter DG; Benedict RHB; Hershey LA
J Parkinsons Dis; 2018; 8(4):539-552. PubMed ID: 30124451
[TBL] [Abstract][Full Text] [Related]
11. Rapid eye movement sleep behavior disorder and risk of dementia in Parkinson's disease: a prospective study.
Postuma RB; Bertrand JA; Montplaisir J; Desjardins C; Vendette M; Rios Romenets S; Panisset M; Gagnon JF
Mov Disord; 2012 May; 27(6):720-6. PubMed ID: 22322798
[TBL] [Abstract][Full Text] [Related]
12. Dementia in Parkinson's disease: a 20-year neuropsychological study (Sydney Multicentre Study).
Reid WG; Hely MA; Morris JG; Loy C; Halliday GM
J Neurol Neurosurg Psychiatry; 2011 Sep; 82(9):1033-7. PubMed ID: 21335570
[TBL] [Abstract][Full Text] [Related]
13. Fatigue and excessive daytime sleepiness in idiopathic Parkinson's disease differently correlate with motor symptoms, depression and dopaminergic treatment.
Valko PO; Waldvogel D; Weller M; Bassetti CL; Held U; Baumann CR
Eur J Neurol; 2010 Dec; 17(12):1428-36. PubMed ID: 20491889
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for dementia, depression and psychosis in long-standing Parkinson's disease.
Giladi N; Treves TA; Paleacu D; Shabtai H; Orlov Y; Kandinov B; Simon ES; Korczyn AD
J Neural Transm (Vienna); 2000; 107(1):59-71. PubMed ID: 10809404
[TBL] [Abstract][Full Text] [Related]
15. Relationship of dementia and visual hallucinations in tremor and non-tremor dominant Parkinson's disease.
Rana AQ; Vaid HM; Edun A; Dogu O; Rana MA
J Neurol Sci; 2012 Dec; 323(1-2):158-61. PubMed ID: 23062324
[TBL] [Abstract][Full Text] [Related]
16. Occurrence risk and structure of depression in Parkinson disease with and without dementia: results from the GEPAD Study.
Riedel O; Heuser I; Klotsche J; Dodel R; Wittchen HU;
J Geriatr Psychiatry Neurol; 2010 Mar; 23(1):27-34. PubMed ID: 20042544
[TBL] [Abstract][Full Text] [Related]
17. Hippocampal volume and white matter disease in the prediction of dementia in Parkinson's disease.
Kandiah N; Zainal NH; Narasimhalu K; Chander RJ; Ng A; Mak E; Au WL; Sitoh YY; Nadkarni N; Tan LC
Parkinsonism Relat Disord; 2014 Nov; 20(11):1203-8. PubMed ID: 25258331
[TBL] [Abstract][Full Text] [Related]
18. Factors determining when to start levodopa/carbidopa/entacapone treatment in Spanish patients with Parkinson's disease.
Martínez-Martín P; Hernández B; Ricart J;
Neurologia; 2014 Apr; 29(3):153-60. PubMed ID: 23465686
[TBL] [Abstract][Full Text] [Related]
19. [Psychometric attributes of the Parkinson's Disease-Cognitive Rating Scale. An independent validation study].
Martínez-Martín P; Prieto-Jurczynska C; Frades-Payo B
Rev Neurol; 2009 Oct 16-31; 49(8):393-8. PubMed ID: 19816841
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic-pharmacodynamic modeling of levodopa in patients with advanced Parkinson disease.
Adamiak U; Kaldonska M; Klodowska-Duda G; Wyska E; Safranow K; Bialecka M; Gawronska-Szklarz B
Clin Neuropharmacol; 2010 May; 33(3):135-41. PubMed ID: 20216409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
